590 filings
Page 5 of 30
4/A
f5tf4i5twoi7hh
21 Mar 22
9 METERS BIOPHARMA / Michael T. Constantino ownership change
4:17pm
4
1ojuumh0jvpyv12f ecy
7 Mar 22
9 METERS BIOPHARMA / Mark A Sirgo ownership change
8:01am
4
hh0 doec5yo7
4 Mar 22
9 METERS BIOPHARMA / John Temperato ownership change
8:00am
8-K
9vxx5ozzzo4t87tdfbz
28 Feb 22
9 Meters Biopharma Provides Clinical Update on Late-Stage Pipeline Products Vurolenatide for Short Bowel Syndrome and Larazotide for Celiac Disease
4:22pm
4
ztcu7wa19yl8t1
23 Feb 22
9 METERS BIOPHARMA / John Temperato ownership change
4:15pm
8-K
gbuqgi2u p92y8vk
11 Feb 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
SC 13G/A
b2jph owc5b1n90e
10 Feb 22
9 METERS BIOPHARMA / ADAGE CAPITAL PARTNERS GP, L.L.C. ownership change
10:35am
SC 13G
9zwz0kdp8xrs tcuk
4 Feb 22
9 METERS BIOPHARMA / BlackRock ownership change
4:12pm
8-K
2te45tmucejqgh0beuf
24 Jan 22
9 Meters Biopharma Announces Allowance of Patent for NM-102 in Combination with Immune Checkpoint Inhibitors
8:06am
4
bd4is6
18 Jan 22
9 METERS BIOPHARMA / Bethany Sensenig ownership change
7:24pm
3
fwjxne mxe7
18 Jan 22
9 METERS BIOPHARMA / Bethany Sensenig ownership change
8:06am
8-K
958fdo5tc d3shj0xm7
18 Jan 22
9 Meters Biopharma Appoints Bethany Sensenig as Chief Financial Officer
8:05am
8-K
3vs8786a8
3 Jan 22
Other Events
7:38am
4
f57d00 1kwb
3 Dec 21
9 METERS BIOPHARMA / Mark A Sirgo ownership change
7:34am
4
ahrixosh
22 Nov 21
9 METERS BIOPHARMA / Mark A Sirgo ownership change
7:30am
4
05p9jbob8q78fqs5kc
19 Nov 21
9 METERS BIOPHARMA / John Temperato ownership change
7:31am
8-K
s6fz8sfb
15 Nov 21
9 Meters Biopharma Provides Business Update and Reports Financial Results for the Third Quarter 2021
7:34am
8-K
hy0 3ey4x53j7ko494wh
10 Nov 21
9 Meters Biopharma, Inc. Announces Immuno-Oncology Collaboration with Gustave Roussy for NM-102, a Gut Microbiome Modulator
7:33am
8-K
7z5xreo
26 Oct 21
2021 Annual Scientific Meeting
7:33am